Literature DB >> 1126441

Artificial blood emulsifiers.

I R Schmolka.   

Abstract

Two sets of prerequisites for nonionic emulsifiers suitable for an artificial blood program are suggested; one set that is necessary and a supplemental set that is desirable. Of the commercially available emulsifiers, only one, poloxamer 188, meets all of the requirements of the first group, and also meets most of the prerequisites of the second group. The hydrophile-lipophile balance system, its relation to emulsifier structure, and its value in arriving at the optimum emulsifier system, are discussed. The ability of the poloxamer 188 to serve as a plasma expander is attributed to its unusual micellar nature. The emulsifiers used in the artificial blood program are reviewed. Some newer experimental fluorochemical surfactants are described, and suggestions made for developing modifications of existing emulsifier systems. A new simple method for preparing stable artificial blood emulsions is reviewed.

Mesh:

Substances:

Year:  1975        PMID: 1126441

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  5 in total

1.  Poloxamer 188 decreases susceptibility of artificial lipid membranes to electroporation.

Authors:  V Sharma; K Stebe; J C Murphy; L Tung
Journal:  Biophys J       Date:  1996-12       Impact factor: 4.033

2.  Poloxamer 188 facilitates the repair of alveolus resident cells in ventilator-injured lungs.

Authors:  Maria Plataki; Yang D Lee; Deborah L Rasmussen; Rolf D Hubmayr
Journal:  Am J Respir Crit Care Med       Date:  2011-07-21       Impact factor: 21.405

3.  Formulation and characterization of echogenic lipid-Pluronic nanobubbles.

Authors:  Tianyi M Krupka; Luis Solorio; Robin E Wilson; Hanping Wu; Nami Azar; Agata A Exner
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

4.  Activities of poloxamer CRL8131 against Mycobacterium tuberculosis in vitro and in vivo.

Authors:  C Jagannath; H S Allaudeen; R L Hunter
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

5.  Enhancement of antibiotic susceptibility and suppression of Mycobacterium avium complex growth by poloxamer 331.

Authors:  R L Hunter; C Jagannath; A Tinkley; C A Behling; F Nolte
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.